Key takeaways
Vyvanse (lisdexamfetamine) and Desoxyn (methamphetamine) are both stimulant medications used to treat attention deficit-hyperactivity disorder (ADHD). Vyvanse is also approved for treating moderate-to-severe binge eating disorder (BED) in adults, while Desoxyn is not. Vyvanse is a first-choice medication for ADHD and is commonly prescribed, whereas Desoxyn is rarely prescribed due to its higher risk of addiction and dependence. Vyvanse is available in both capsule and chewable tablet forms, while Desoxyn is only available as a tablet. Both medications can cause side effects like difficulty sleeping and loss of appetite, but Vyvanse is known to cause dry mouth and irritability more frequently. Additionally, both medications carry risks of serious heart problems, changes in behavior or thoughts, and serotonin syndrome. However, Vyvanse is considered safer for long-term use compared to Desoxyn, which has a higher potential for misuse and dependency.
